Just Earth News | @justearthnews | 04 May 2021, 01:20 am Print
Pfizer-BioNTech Image: Pixabay
Washinton/Sputnik: The US Food and Drug Administration (FDA) is preparing to approve the Pfizer-BioNTech COVID-19 vaccine for those aged 12 to 15, The New York Times reported, citing federal officials.
The authorization is expected to come early next week, the report said on Monday.
Pfizer announced several weeks ago that none of the adolescents who have received the vaccine during trials have contracted a symptomatic case of COVID-19.
However, plans to vaccinate teens and children, who rarely contract serious cases of the illness, have sparked debate, the report added, as many question whether excess US vaccines could be put to better use on adults in other countries.
- Fatty liver could be quietly doubling your heart attack risk, shocking study finds
- New study reveals 8 percent of Americans have no health insurance coverage
- New Ebola crisis: Russia claims creating vaccine that can work against deadly Bundibugyo variant
- Global panic warning? WHO chief demands immediate Ebola action plan
- US adds Atlanta, Houston to Ebola screening list ahead of World Cup
